Related Experiment Video
Updated: Oct 11, 2025
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
Potential prognostic value of miR-132 and miR-212 expression in mCRPC patients
Mariano Pontico1, Viviana Frantellizzi2, Luca Cindolo3
1Program in Morphogenesis and Tissue Engineering, Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome. mariano.pontico@uniroma1.it.
Abstract:
To the Editor, we have been very pleased to read the interesting work proposed by Salemi et al. regarding the expression of specific fragments of microRNA (miRNA), particularly miR-132 and miR-212, as potential key regulators in prostate cancer (PCa). As outlined by the Authors, the altered expression of miRNAs in cancer pathogenesis represents a well-consolidated knowledge in the current literature. More specifically, both miR-212 and miR-132 regulate subsets of genes involved in tumor progression in several tumor cell types as PCa, proving a central role in tumorigenesis, cell adhesion, and angiogenesis. In addition, a strong association between miR-132 expression and high Gleason score PCa has been lately depicted [...].
Insights
Specific microRNAs, miR-132 and miR-212, are key regulators in prostate cancer (PCa) progression. Their altered expression is linked to tumorigenesis, cell adhesion, and angiogenesis, with miR-132 associated with high Gleason scores.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) play a significant role in cancer pathogenesis.
- Altered expression of specific miRNAs, including miR-132 and miR-212, is implicated in various cancers.
- These miRNAs regulate genes involved in critical cancer processes.
Purpose of the Study:
- To highlight the role of miR-132 and miR-212 as potential regulators in prostate cancer (PCa).
- To discuss the association between these miRNAs and key aspects of PCa development and progression.
Main Methods:
- Literature review and analysis of existing research on miRNA expression in prostate cancer.
- Focus on studies investigating miR-132 and miR-212 function and expression levels.
Main Results:
- miR-132 and miR-212 are involved in regulating genes critical for tumor progression, cell adhesion, and angiogenesis in PCa.
- A notable association exists between miR-132 expression and higher Gleason scores in prostate cancer patients.
Conclusions:
- miR-132 and miR-212 are crucial regulators in prostate cancer pathogenesis.
- Their expression patterns offer potential as biomarkers for PCa aggressiveness and progression.
